The incident on the MV Hondius cruise ship, where a hantavirus outbreak occurred, has brought to light some significant weaknesses in the US public health system. This is a troubling sign, especially as it raises concerns about our ability to quickly contain such outbreaks and prepare for potential future pandemics involving more widespread pathogens. While passengers and their close contacts are certainly at risk and need to follow public health guidelines, for most people, the danger of hantavirus is extremely low. Experts anticipate that more cases from this incident will be identified, but they are very clear that a hantavirus pandemic is highly improbable. As Maria Van Kerkhove, director of epidemic and pandemic management at the WHO, emphasized, “This is not Covid, this is not influenza. It spreads very, very differently. This is not the same situation we were in six years ago… It’s very different.” The WHO has been actively coordinating a global response, but notably, the US leadership has been conspicuously absent from these efforts. This is largely due to the previous administration’s decision to withdraw from the organization shortly after taking office. This situation, though not a sign of pandemic potential for hantavirus, serves as a stark warning. It reveals how recent cuts to the US public health infrastructure have severely hampered the ability of officials and scientists to effectively track and understand pathogens like these. This has disturbing implications not only for rare outbreaks but for overall pandemic preparedness. Currently, there are three suspected and five confirmed cases of Andes virus, a type of hantavirus. While typically spread by rodents, it can, in some instances, spread through close, intimate contact. Tragically, three people have died, and three others have been hospitalized, including some in intensive care, though officials reported on Thursday that these patients are showing signs of improvement. Interestingly, one of the patients, a Dutch flight attendant, has tested negative for the Andes virus.
Many, like Dr. Bill Hanage, an epidemiology professor at the Harvard TH Chan School of Public Health, express minimal personal concern about the global impact of this specific hantavirus outbreak, stating his “personal worry is essentially zero.” He believes the vast majority of the world has nothing to worry about and that individuals should simply pay attention to public health warnings if they are told their risk is higher. However, Dr. Hanage is deeply concerned that continuous cuts in health leadership, coupled with the increasing spread of misinformation and a growing distrust in public health measures, could severely complicate efforts to contain any onward transmission. This “radio silence” from officials, as Dr. Boghuma Titanji, an infectious disease physician and assistant professor at the Emory School of Medicine, describes it, is particularly alarming. She argues it “just fuels public anxiety,” especially given the lingering emotional wounds from the COVID-19 pandemic. Many people are still experiencing a form of PTSD from that trauma, making it incredibly difficult to avoid spiraling when faced with a new, unknown threat. Dr. Titanji points out a significant departure from standard US practice: the Centers for Disease Control and Prevention (CDC) has not held a briefing or created a public information page, nor have top officials appeared on TV to discuss the risks to Americans. In stark contrast, the European Centre for Disease Prevention and Control deployed two Dutch physicians and an infectious disease expert to the cruise ship to provide medical and psychosocial support. Dr. Titanji laments the absence of the typical CDC presence, stating, “A [US] CDC crew would have been with them, or at least been offered. Now they’re nowhere to be found.” However, recent reports from CNN indicate that the CDC is dispatching staff to meet the ship in the Canary Islands and has plans to charter a flight to bring American passengers back to the US. A separate CDC team is also reportedly heading to Nebraska, where passengers are expected to be quarantined to prevent any further spread. The US Department of State has now taken the lead in the US response, as per the CDC’s first and only press release on the issue, issued days after initial concerns arose. This move is highly unusual, as Dr. Titanji notes, since the CDC, with decades of experience in responding to Andes virus outbreaks, would typically be at the forefront of health coordination. A CDC official stated that the agency is providing “technical input and guidance as requested,” but notably declined a request from The Guardian to speak with a hantavirus expert and did not answer questions about the agency’s testing and laboratory capacity, recommended precautions for returning passengers, or how they plan to support local health providers. For rare diseases that physicians might only encounter once or twice in their careers, the typical first step is to contact the CDC for guidance on testing, diagnosis, and containment. Dr. Titanji worries, “We’re losing that type of support.”
The US public health system has undeniably taken a beating under the previous administration, leaving key agencies significantly weakened. Staff layoffs and firings have led to a “hollowing out” of these crucial organizations, with many dedicated professionals leaving out of frustration. Critical positions have been left unfilled, further exacerbating the problem. For instance, all full-time cruise ship inspectors at the CDC were abruptly laid off last year, even as they were actively investigating two outbreaks. Research, particularly the kind of virological work that could shed light on hantavirus transmission, has become heavily politicized and funding has been severely cut. On top of that, funding for the rapid development of new vaccines has been halted, while a wave of misinformation about vaccines continues to flourish, eroding public trust. The impact is also felt in laboratory capacity. The ranks of laboratory staff have been significantly depleted, leaving it unclear whether the US even has adequate tests and laboratory capabilities for hantaviruses. Astonishingly, states can no longer send samples to the CDC for orthopoxvirus testing, like mpox, because that division has been temporarily paused. Furthermore, labs can no longer test to identify the specific parasite causing leishmaniasis, and rabies testing at the CDC was also temporarily halted in April. Research into virology itself has faced intense political scrutiny and limitations. An executive order in May sought to curb research on viruses, and the National Institutes of Health implemented sweeping cuts to this vital work. Lawmakers have also introduced bills to curtail what they vaguely label “gain of function” research. Despite a strong scientific consensus pointing to a natural spillover of Sars-CoV-2 from animals to humans, officials continue to investigate a lab leak scenario, leading to scientists facing subpoenas, arrests, and even prosecution. Dr. Hanage rightly points out the irony: “We should be investing in doing more to understand how these spillover events take place – and that’s actually the very opposite of what’s going on at the moment.” This damage isn’t confined to the federal level. More than half of US states have passed laws restricting health officials’ ability to mandate quarantine and isolation or recommend masks. Some schools are now prevented from requiring certain vaccines for attendance and are even forbidden from closing down during a health crisis. Dr. Titanji finds the current response to the hantavirus outbreak, which is not considered a high-consequence virus, deeply unsettling. She warns, “If we had a significant outbreak of a high-consequence pathogen, it would be very, very concerning to see what the response and the leadership of that response would be.”
Despite the worrying state of US public health infrastructure, the World Health Organization (WHO) is actively working to understand the human-to-human transmission in this specific hantavirus outbreak. While it’s clear that the spread is largely confined to those who had very close contact, this mirrors a similar outbreak in Argentina in late 2018 and early 2019, where 34 people tested positive and 11 died. Maria Van Kerkhove from the WHO believes a similar pattern is emerging here, with transmission from the initial two patients to their close contacts, including the doctor who treated them on the cruise ship. Abdirahman Mahamud, an infection prevention control specialist at the WHO, emphasizes the importance of applying lessons learned from Argentina: “If we follow public health measures and the lesson we learned from Argentina now is shared across all countries – what needs to happen in contact tracing, isolation – we can break this chain of transmission.” This proactive approach, including robust contact tracing and immediate isolation, is precisely how a patient in Switzerland was identified, demonstrating good “public health action in the works,” according to Van Kerkhove. Passengers from twelve different countries, including the US, disembarked from the ship before the outbreak was even discovered and have since returned home. Following up with these individuals, and anyone else they may have encountered if they were ill during their travels, is critical work. Dr. Hanage stresses the urgency for “extremely aggressive contact tracing of everybody who left the boat,” and that they “should be quarantined.” He acknowledges that this situation might be more complex than the one in Argentina due to “multiple authorities and multiple jurisdictions,” which could make coordinating an adequate response more time-consuming. Given the prevalence of misinformation and the existing distrust in officials in the US, “it remains to be seen” how diligently people will follow health guidance, and how willing authorities will be to implement it, especially after the backlash experienced during the COVID-19 pandemic. However, Dr. Hanage remains cautiously optimistic: “Everything that we know about both this outbreak and previous ones indicates that this is controllable, and I expect that it will be controlled. How long it will take to be controlled is another question. The appetite for that control will be a major part in deciding how easily it’s done and how long it ultimately takes.”
Even though the US has politically withdrawn from the WHO, it has not yet withdrawn from the International Health Regulations (IHR). This is a crucial detail, as it means US officials are still privy to all the latest technical information and guidance from the global health body. Abdirahman Mahamud of the WHO confirmed that “in terms of collaboration with US and US institutions, it has been going very well. The information flow is there, transparent and frank.” However, he underscores a critical point: “this outbreak has seen why the world needs a global entity that coordinates” the response. This sentiment is echoed by Tedros Adhanom Ghebreyesus, the Director-General of the WHO, who highlighted the immense importance of a platform like the WHO. He expressed hope that both the US and Argentina would “reconsider” their decisions to leave the organization, emphasizing that “any vacuum, any space which is not covered, actually gives advantage to the virus. And the best immunity we have is solidarity.” This points to a larger, philosophical argument about global health: viruses don’t respect borders, and a fragmented, uncoordinated response only empowers them. The hantavirus outbreak, while not a global pandemic threat, serves as a stark reminder that robust international collaboration and a strong, trusted global health body are not luxuries but necessities for safeguarding public health worldwide. The challenges faced in this particular situation – from internal national public health system weaknesses to the complexities of international coordination – are all vital lessons for future, potentially more severe, health crises. The human element here is clear: fear, misinformation, and political decisions can deeply impact our collective ability to protect ourselves and our communities, reminding us that trust and solidarity are our strongest defenses against any pathogen.